Schizophrenia trials recruiting in North Carolina

All Schizophrenia trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
  NCT06540833 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · North Carolina: Charlotte
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · North Carolina: Greensboro, Matthews, Morehead City, Shelby
• Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  NCT05208190 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
  NCT07379827 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Cary, Wilmington
• Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
  NCT07101094 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Kinston, Rose Hill
• Examining the Effects of Estradiol on Neural and Molecular Response to Reward
  NCT05282277 · Phase: Phase 4 · Ages: 45 Years to 55 Years · Sex: Female · North Carolina: Chapel Hill
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
  NCT05303064 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · North Carolina: Kinston